These results indicate that development of cachexia in HF‐patients is linked with major changes in EAT metabolome and suggest an involvement of at least some of the VIP analytes in the mechanisms underlying pathological wasting of adipose tissue. The gene discussed is VIP; the disease is Cachexia.